/PRNewswire/ Elevation Oncology, Inc. (Nasdaq: ELEV), an innovative oncology company focused on the discovery and development of selective cancer therapies.
/PRNewswire/ REGENXBIO Inc. (Nasdaq: RGNX) today announced it will participate in the following upcoming investor conferences: Credit Suisse 31st Annual.
At theNATO Edge 2022 Conference in Lotto Mons Expo, Belgium (NATOedge, October 25-27), Taqtile the leader in augmented reality (AR)-based work-instruction solutions, will participate on a panel exploring
/PRNewswire/ Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), (NEO: MMED), (the "Company" or "MindMed"), a clinical stage biopharmaceutical company developing.